InvestSMART

Nexalis Therapeutics Ltd (ASX:NX1)

ALERT: Price-sensitive ASX Announcement for NX1
Current share price for NX1 : $0.011 -0.014 (-56%)+
Release
28 May 2026 9:48AM
Price at Release
$0.025
Full Release
download
Summary
Nexalis Therapeutics Ltd, trading under the code ASX: NX1, has been reinstated to official quotation on the Australian Securities Exchange (ASX) following the release of a significant announcement concerning its existing debt facility. This move marks the lifting of a prior suspension of trading in the company's securities. The reinstatement allows investors and the company to resume normal trading activities and reflects a pivotal moment in addressing its financial strategies.
Key Points
  • Reinstatement to official quotation on the ASX.
  • Suspension of trading lifted for Nexalis Therapeutics Ltd.
  • Announcement related to existing debt facility.
  • ASX compliance issued the reinstatement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.